Avita Medical Inc Reports Results For The Quarter Ended December 31: Earnings Summary

AVITA Medical

13/02/2025 23:29

* AVITA Medical Inc  RCEL.OQ  reported a quarterly adjusted
loss
of 44 cents​​ per share for the quarter ended December 31, lower
than the same quarter last year, when the company reported EPS
of -28 cents.  The mean expectation of seven analysts for the
quarter was for a loss of 43 cents per share. Wall Street
expected results to range from -61 cents to -20 cents per share.
    * Revenue rose 29.7% to $18.41 million from a year ago;
analysts
expected $21.04 million. 
    * AVITA Medical Inc's reported EPS for the quarter was a
loss
of 44 cents​.
    * The company reported a quarterly loss of $11.59 million.
    * AVITA Medical Inc shares had fallen by 32.7% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 21.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for AVITA Medical Inc
is $15.00 
This summary was machine generated from LSEG data February 13 at
11:29 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.43          -0.44          Missed
 Sep. 30 2024      -0.44          -0.62          Missed
 Jun. 30 2024      -0.52          -0.60          Missed
 Mar. 31 2024      -0.47          -0.73          Missed